Anavex Life Sciences Corp (AVXL)

NASDAQ · Health Care

$1.19 -8.46% Close Oct 30, 2026 Live

Anavex Life Sciences stock today

Anavex Life Sciences closed at $1.19 on October 30, 2026, down 8.46% on the day. Over the past year it returned -85.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $110 million.

$2.00$4.00$6.00$8.00
NovJan 2026MarMayJulSep
Total return with dividends reinvested, to the close on Oct 30, 2026
PeriodAVXLS&P 500 (SPY)
1 month-41.1%-0.9%
3 months-55.9%+2.1%
Year to date-66.6%+11.7%
1 year-85.2%+12.4%
3 years-78.4%+88.5%
5 years-93.6%+76.0%

Key statistics

Market value
$110M
52-week range
$1.19 to $8.03
Next report
Nov 24, 2026 (estimated)

About Anavex Life Sciences

Develops small-molecule drug candidates for neurodegenerative and neuro-oncologic diseases.

Sector: Health Care

More on Anavex Life Sciences

No forecast, no recommendation. This page describes Anavex Life Sciences Corp from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.